Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events

2002281 citationsReview

Authors

Steven M. Weisman · Morristown Medical Center

David Y. Graham · Innovative Scientific Solutions (United States)

Abstract

Aspirin use for the secondary prevention of thromboembolic events has a favorable benefit-to-risk profile and should be encouraged in those at high risk.

Topics & Keywords

Antiplatelet Therapy and Cardiovascular Diseases Inflammatory mediators and NSAID effects Lipoproteins and Cardiovascular Health

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Internal Medicine

Volume 162, Issue 19, pp. 2197-2197

DOI: 10.1001/archinte.162.19.2197

Field-Weighted Citation Impact: 9.09